Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
2 of the Best Healthcare Stocks You'll Find Today
02:00pm, Friday, 30'th Apr 2021
The advice of Warren Buffett's biggest influencers supports these solid picks.
Illumina To Webcast Upcoming Investor Conference
05:30pm, Thursday, 29'th Apr 2021
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Bank of America 2021 Healthcare Con
Illumina Files Action for Annulment of European Commission's Decision Asserting Jurisdiction to Review GRAIL Acquisition
09:05am, Thursday, 29'th Apr 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) announced today that it has filed an action in the General Court of the European Union asking for annulment of the European Commission's decis
Illumina (ILMN) Q1 Earnings Top Estimates, Margins Decline
10:47am, Wednesday, 28'th Apr 2021
Illumina (ILMN) exhibits an impressive performance by its Instruments segment in the first quarter of 2021 despite pandemic-led business disruptions.
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
09:05am, Wednesday, 28'th Apr 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina announced commitment of $60 million to a global pathogen genomics initiative, in partnership with the Bill & Melinda Gates Foundation.
How Illumina's Q1 Results Delighted Investors
06:04am, Wednesday, 28'th Apr 2021
Nearly everything went right for the genomic sequencing pioneer.
Illumina, Inc. (ILMN) CEO Francis deSouza on Q1 2021 Results - Earnings Call Transcript
09:51pm, Tuesday, 27'th Apr 2021
Illumina, Inc. (ILMN) CEO Francis deSouza on Q1 2021 Results - Earnings Call Transcript
Illumina (ILMN) Q1 Earnings and Revenues Top Estimates
06:02pm, Tuesday, 27'th Apr 2021
Illumina (ILMN) delivered earnings and revenue surprises of 38.97% and 0.74%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Illumina (ILMN) This Earnings Season?
09:01am, Monday, 26'th Apr 2021
Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
06:35am, Saturday, 24'th Apr 2021
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
04:05pm, Thursday, 22'nd Apr 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina and Kartos Therapeutics announce a new partnership to co-develop a TP53 CDx based on the TruSight™ Oncology 500 (TSO 500) assay.
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
06:30am, Tuesday, 20'th Apr 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina disagrees with the European Commission's Directorate-General for Competition's decision to review Illumina's acquisition of GRAIL.
3 Biden Healthcare Stocks to Watch
06:42am, Saturday, 17'th Apr 2021
The administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks.
Is Illumina Still a Buy Without the GRAIL Acquisition?
08:54am, Thursday, 15'th Apr 2021
Sometimes the most carefully laid plans hit unforeseen snags.
The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance
07:01am, Wednesday, 14'th Apr 2021
The gene sequencing giant has a couple of key challenges going forward.
